NeoChord's Series B - III Round

NeoChord raised a round of funding on March 15, 2013.

NeoChord is a medical technology company focused on advancing the treatment of mitral regurgitation. The Company expects to commercialize a surgical device for minimally invasive mitral valve repair v…

Articles about NeoChord's Series B - III Round: